Author:
Hill Andrew,Tahat Loai,Mohammed Mohammed Khalil,Tayyem R.abab Fayez,Khwairakpam Giten,Nath Sanjay,Freeman James,Benbitour Ismahane,Helmy Sherine
Subject
Virology,Infectious Diseases,Public Health, Environmental and Occupational Health,Immunology,Epidemiology
Reference9 articles.
1. Generic treatments for HIV, HBV, HCV, TB could be mass produced for >$90 per patient;Gotham;9th IAS Conference on HIV Science,2017
2. ENDURANCE-3: safety and efficacy of glecaprevir/pibrentasvir compared to sofosbuvir plus daclatasvir in treatment-naïve HCV genotype 3-infected patients without cirrhosis;Foster;J Hepatol,2017
3. The Egyptian HCV Control Program; 2016;Doss;International Viral Hepatitis Elimination (IVHEM) 2017,2017
4. World Health Organization. Prequalification of medicines by WHO. Available at:www.who.int/mediacentre/factsheets/fs278/en/ (accessed March 2018).
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献